IL314508A - Theragnostic folate conjugates - Google Patents

Theragnostic folate conjugates

Info

Publication number
IL314508A
IL314508A IL314508A IL31450824A IL314508A IL 314508 A IL314508 A IL 314508A IL 314508 A IL314508 A IL 314508A IL 31450824 A IL31450824 A IL 31450824A IL 314508 A IL314508 A IL 314508A
Authority
IL
Israel
Prior art keywords
tragnostic
acid pairs
pairs
acid
tragnostic acid
Prior art date
Application number
IL314508A
Other languages
English (en)
Hebrew (he)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL314508A publication Critical patent/IL314508A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL314508A 2022-02-01 2023-01-30 Theragnostic folate conjugates IL314508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22154652 2022-02-01
PCT/EP2023/052117 WO2023148116A1 (en) 2022-02-01 2023-01-30 Theragnostic folate conjugates

Publications (1)

Publication Number Publication Date
IL314508A true IL314508A (en) 2024-09-01

Family

ID=80118841

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314508A IL314508A (en) 2022-02-01 2023-01-30 Theragnostic folate conjugates

Country Status (9)

Country Link
US (1) US20250127938A1 (cg-RX-API-DMAC7.html)
EP (1) EP4472677A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025504027A (cg-RX-API-DMAC7.html)
KR (1) KR20240146013A (cg-RX-API-DMAC7.html)
CN (1) CN118647412A (cg-RX-API-DMAC7.html)
AU (1) AU2023216406A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243584A1 (cg-RX-API-DMAC7.html)
IL (1) IL314508A (cg-RX-API-DMAC7.html)
WO (1) WO2023148116A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025227100A2 (en) * 2024-04-26 2025-10-30 Purdue Research Foundation Targeted delivery of therapeutic agent to retinal pigment epithelium in treatment of ocular diseases

Also Published As

Publication number Publication date
AU2023216406A1 (en) 2024-09-19
KR20240146013A (ko) 2024-10-07
EP4472677A1 (en) 2024-12-11
WO2023148116A1 (en) 2023-08-10
CN118647412A (zh) 2024-09-13
CA3243584A1 (en) 2023-08-10
JP2025504027A (ja) 2025-02-06
US20250127938A1 (en) 2025-04-24

Similar Documents

Publication Publication Date Title
EP4582426A4 (en) PAN-KRAS INHIBITOR COMPOUND
EP4610263A4 (en) PAN-KRAS INHIBITOR COMPOUND
EP4472980A4 (en) QUINAZOLINE PAN-KRAS INHIBITORS
EP4479045A4 (en) NLRP3 INHIBITORS
EP4523042A4 (en) TIME COMPARTMENT QUANTUM BIT CONVERTER
EP4499646A4 (en) NLRP3 Inflammasome Inhibitors
EP4161580A4 (en) BIOCONJUGATES OF CANNABINOID HYALURONIC ACID
EP4483817A4 (en) OCCLUSION DEVICE
EP4504767A4 (en) CHIMERIC CYTOKINE RECEPTORS
EP4504722A4 (en) LRRK2 INHIBITORS
EP4499630A4 (en) BCL-XL INHIBITORS
EP4520976A4 (en) TURBOCHARGER
DE112023002022A5 (de) Isomatte
EP4547866A4 (en) NUCLEIC ACID PROBES
EP4582049A4 (en) MICROCHAMP
EP4497397A4 (en) OCCLUSION DEVICE
EP4501308A4 (en) HAIR WASHING COMPOSITION
EP4241545C0 (fr) Bineuse universelle
EP4332223A4 (en) ANTIVIRAL NUCLEIC ACID
CA3260666A1 (en) Combination therapies
EP4062976C0 (en) CARBALYSOPHOSPHATIDIC ACID
EP4573214C0 (en) NUCLEIC ACID AMPLIFICATION
CN309834577S (zh) 电子烟
DK4584243T3 (da) Tværbinder
ES1305503Y (es) Colpotomizador